JWJinyong Wu

Jinyong Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinyong Wu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Han Cao

    School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China

    1 shared publication
  • Hongying Yang

    School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China

    1 shared publication
  • Jianping Cao

    State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou, China

    1 shared publication
  • Jiao Xue

    School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China

    1 shared publication
  • Judong Luo

    Department of Radiotherapy, Changzhou Tumor Hospital, Soochow University, Changzhou 213001, China

    1 shared publication
  • Shuyu Zhang

    Laboratory of Radiation Medicine, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu 610041, China

    1 shared publication

Latest Publications

  • Open Access

    HIV-TAT mediated protein transduction of Cu/Zn-superoxide dismutase-1 (SOD1) protects skin cells from ionizing radiation

    by Qing Gu, Tienan Feng, Han Cao, Yiting Tang, Xin Ge, Judong Luo, Jiao Xue, Jinyong Wu, Hongying Yang, Shuyu Zhang, et al.

    Background: Radiation-induced skin injury remains a serious concern during radiotherapy. Cu/Zn-superoxide dismutase (Cu/Zn-SOD, SOD1) is a conserved enzyme for scavenging superoxide radical in cells. Because of the integrity of cell membranes, exogenous molecule is not able to be incorporated into cells, which limited the application of natural SOD1. The aim of this study was to evaluate the protective role of HIV-TAT protein transduction domain mediated protein transduction of SOD1(TAT-SOD1) against ionizing radiation.Methods: The recombinant TAT-SOD1and SOD1were obtained by prokaryotic–based protein expression system. The transduction effect and biological activity of TAT-SOD1was measured by immunofluorescence and antioxidant capability assays in human keratinocyte HaCaT cells. Mito-Tracker staining, reactive oxygen species (ROS) generation assay, cell apoptosis analysis and malondialdehyde (MDA) assay were used to access the protective effect of TAT- SOD1.Results: Uptake of TAT-SOD1by HaCaT cells retained its biological activity. Compared with natural SOD1, the application of TAT-SOD1significantly enhanced the viability and decreased the apoptosis induced by X-ray irradiation. Moreover, TAT-SOD1reduced ROS and preserved mitochondrial integrity after radiation exposure in HaCaT cells. Radiation-induced γH2AX foci, which are representative of DNA double strand breaks, were decreased by pretreatment with TAT-SOD1. Furthermore, subcutaneous application of TAT-SOD1resulted in a significant decrease in 45 Gy electron beam-induced ROS and MDA concentration in the skins of rats.Conclusions: This study provides evidences for the protective role of TAT-SOD1in alleviating radiation-induced damage in HaCaT cells and rat skins, which suggests a new therapeutic strategy for radiation-induced skin injury.